HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

syringomycin E

lipodepsinonapeptide antibiotic from Pseudomonas syringae; structure given in first source

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - syringomycin E: 3
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - syringomycin E: 3

Experts

1.	Efimova, Svetlana S: 1 article (01/2020)
2.	Ostroumova, Olga S: 1 article (01/2020)
3.	Sarkisyan, Zara M: 1 article (01/2020)
4.	Yakovlev, Igor P: 1 article (01/2020)
5.	Yuskovets, Valeriy N: 1 article (01/2020)
6.	Zakharova, Anastasiia A: 1 article (01/2020)
7.	Szabó, Zsófia: 1 article (01/2003)

Related Diseases

1.	Candidiasis (Moniliasis) 08/01/1998 - "Efficacy of syringomycin E in a murine model of vaginal candidiasis." 08/01/1998 - "Syringomycin E (SR-E), a new antifungal produced by the bacterium Pseudomonas syringae pv. syringae, was evaluated in a murine vaginal candidiasis model. "
2.	Hemolysis 01/01/2003 - "The syringomycin E, studied earlier by our research group, formed pores on human red blood cells (RBC), and caused also partially hemolysis. "
3.	Invasive Fungal Infections 01/01/2020 - "The dramatic increase in transmembrane current induced by syringomycin E, nystatin, and fengycin upon C6 treatment suggests its potential in combination therapy for treating invasive fungal infections."

Related Drugs and Biologics

1.	Nystatin (Mycostatin)
2.	fengycin

Related Therapies and Procedures

1.	Therapeutics